Samraat S. Raha

Samraat S. Raha

President and Chief Executive OfficeratMyriad Genetics· In proxies 2023–2025

Pay in FY2025+30% from the year before · Myriad Genetics stock -55.1% the same year

Samraat S. Raha was paid $5.7M in FY2025 (Dec), up 30%. Myriad Genetics stock fell 55.1% that year.

Pay$100 in the stock at the end of FY23 → $32
Pay is from the Summary Compensation Table of each Myriad Genetics proxy. The stock line is the value of $100 put in the stock at the start, from the price change of each fiscal year. Dividends are not in it.

Experience

  1. Myriad GeneticsPublic company · 3 yr
    • President and Chief Executive Officer2023 – Present · 3 yrStock in role -57%

Roles come from the proxy statements of each company.

Boards1

  • Myriad GeneticsDirector · 4 yr on the boardNot independent—Paid as an executive

Board seats come from each company's latest proxy statement.

Activity

For the press:Download CSVDownload PNGHow to use our data

Two people shown as one, or a wrong number?